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Saccharomyces cerevisiae transport protein particle (TRAPP) is a family of related multisubunit complexes required for
endoplasmic reticulum-to-Golgi transport (TRAPP I), endosome-to-Golgi transport (TRAPP II) or cytosol to vacuole
targeting (TRAPP III). To gain insight into the relationship between these complexes, we generated random and targeted
mutations in the Trs23p core subunit. Remarkably, at physiological salt concentrations only two peaks (TRAPP I and a
high molecular weight peak) are detected in wild-type cells. As the salt was raised, the high molecular weight peak
resolved into TRAPP II and III peaks. Deletion of a Saccharomycotina-specific domain of Trs23p resulted in destabilization
of TRAPP I but had no effect on TRAPP II or III. This mutation had no observable growth phenotype, normal levels of
Ypt1p-directed guanine nucleotide exchange factor activity in vivo and did not display any in vivo nor in vitro blocks in
membrane traffic. Biochemical analysis indicated that TRAPP I could be produced from the TRAPP II/III peak in vitro by
increasing the salt concentration. Our data suggest that the SMS domain of Trs23p is responsible for the in vitro
appearance of TRAPP I in S. cerevisiae. The implications of these findings are discussed.
Introduction
Newly synthesized proteins destined for secretion are packaged
into COP II-coated transport vesicles at the endoplasmic reti-
culum (ER).
1 These vesicles are then recognized by and fuse with
the earliest (cis) Golgi compartment. Similar budding, recognition
and fusion events take place from nearly every endomembrane
compartment within the cell, and understanding how each vesicle
is specifically recognized has represented a major focus of efforts in
the field of vesicle transport. Many factors participate in the
overall process including SNAREs, Ypt/Rab GTPases, vesicle coat
proteins and vesicle tethers.
2,3 While SNAREs were originally
postulated to impart specificity in vesicle transport,
4 it is now
accepted that all of the other aforementioned factors can function
upstream of the SNAREs and thus participate in specificity.
Upon arrival at a target membrane, the vesicle is recognized by
any one of a number of possible tethering factors. These tethering
factors have been classified as either coiled-coil proteins or large
multisubunit tethering complexes (MTC).
5,6 The tethering event
leaves open many questions such as which tethering factor acts
first or if they act simultaneously, and whether the mechanism of
tethering is conserved at the various compartments. Nonetheless,
it has been suggested that the tethering factors are among the
first contacts between the vesicle and the target membrane and,
as such, may contribute to the exquisite specificity in vesicle
transport.
6
One of the earliest MTCs identified was the TRAPP com-
plex.
7,8 Although this complex has not been demonstrated to
tether two distinct membranes together, it is believed to accom-
plish this either directly or by leading to recruitment of the factor
(s) that does this. In the yeast S. cerevisiae there are three forms of
the complex called TRAPP I, II and III.
7,9-11 As such, TRAPP
poses a unique set of problems with respect to the role of these
complexes in determining specificity in this organism. All three
complexes contain the same “core” of six polypeptides (Bet3p,
Bet5p, Trs20p, Trs23p, Trs31p, Trs33p) with TRAPP II
containing four additional subunits (Tca17p, Trs65p, Trs120p,
Trs130p) and TRAPP III containing one additional subunit
(Trs85p). While TRAPP I has been implicated in ER-to-Golgi
transport,
7,11 TRAPP II has been shown to function at a later
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Golgi compartment
7,9 and TRAPP III was suggested to function
in autophagy.
10,12,13 Confounding the problem of TRAPP-
mediated specificity is the fact that Bet3p, a common subunit
found in two copies within the core,
14-16 was shown to bind to
Sec23p, a component of the ER-derived COP II coat,
17
suggesting that the Sec23p-binding site on all copies of Bet3p
must be blocked in both TRAPP II and III. In addition, this core
of the complex was shown to be sufficient for Ypt1-directed
guanine nucleotide exchange factor (GEF) activity
15 and indeed
all three complexes have been reported to be capable of such
activity.
7,10,11,18,19 Finally, to date only one complex has been
reported in mammalian cells and it was recently shown that this
complex contains homologs of the S. cerevisiae TRAPP II- and
III-specific proteins.
20-22
In an effort to better understand the relationship between the
TRAPP complexes, we focused on Trs23p that links two Bet3p-
containing subcomplexes to form the TRAPP holocomplex,
14,15
thus providing GEF activity. In addition, Trs23p interacts with
the GTPase Ypt1p.
14 Also unique to this subunit is a PDZ-like
domain in higher eukaryotes and a Saccharomycotina-specific
domain seen in the S. cerevisiae protein.
14,15,23,24 Furthermore, co-
expression of the core proteins leads to assembly of a functional
complex when using the S. cerevisiae proteins but the mammalian
proteins fail to assemble,
15 suggesting differences in the assembly
and/or stability of the core between both organisms.
Using random and targeted mutagenesis we have constructed
a series of mutations in Trs23p. We show that neither the C-
terminal 99 amino acids (trs23D99C) nor the Saccharomycotina-
specific domain (trs23DSMS) of Trs23p are essential for viability.
A more extensive characterization of trs23DSMS showed no
growth defect and that TRAPP I subunits are shifted to a much
smaller molecular size suggesting that this domain is responsible
for the appearance of TRAPP I in vitro. The absence of TRAPP I
did not affect ER-to-Golgi traffic either in vivo or in vitro, nor
later Golgi traffic or autophagy. We demonstrate that under
physiological conditions TRAPP II co-fractionates with TRAPP
III, and this is the only source of TRAPP seen in trs23DSMS.
Importantly, we demonstrate that the fraction containing a
mixture of TRAPP II and III can be induced to produce TRAPP I
and dimeric TRAPP II by incubation in high salt. Finally, we
show that in contrast to S. cerevisiae, the closely-related yeast
Pichia pastoris, which lacks the SMS domain in Trs23p, does not
contain a TRAPP I peak. Our data suggest that the SMS domain
stabilizes the TRAPP I core complex and that this complex may
be an in vitro anomaly. The implications of these findings on
membrane trafficking are discussed.
Results
Neither the C-terminal 99 residues nor the SMS domain of
Trs23p are essential. In an effort to examine the role of the
Trs23p subunit in TRAPP function, we conducted a random
mutagenesis screen using hydroxylamine to identify conditional
mutations in TRS23. This screen identified a mildly temperature
(heat)-sensitive (ts) and cold sensitive (cs) mutant. Upon sequenc-
ing of the mutation, TRS23 was found to contain a C361T
mutation that introduced a nonsense mutation following the
120th amino acid (herein referred to as trs23D99C), indicating
that the C-terminal 99 amino acids of Trs23p are not essential
for vegetative growth of the yeast (Fig.1A-C). Further C-terminal
truncations generated by either random (trs23D167C,
trs23D202C) or site-directed (trs23D109C) mutagenesis were
found to be lethal (Fig.1A and C). Alignment of S. cerevisiae
Trs23p with its human counterpart (TRAPPC4) indicates that
residues 56–115 comprise a domain not found in higher
eukaryotes (Fig.1D; also see ref. 15). This domain is only
present in species within the Saccharomycotina phylum and,
hence, we will refer to it as the Saccharomycotina-specific (SMS)
domain. Since truncation of Trs23p that removed even a small
portion of this domain (trs23D109C) resulted in lethality, we
tested whether the SMS domain itself was essential for function
by deleting this domain (herein referred to as trs23DSMS). This
mutant did not display a discernible growth phenotype at either
extreme temperature tested (Fig.1B and C) suggesting it is not
essential for function. Furthermore, truncations of Trs23p from
the N-terminus (removal of the first 15 amino acids) resulted
in lethality (Fig.1A and C). Collectively, our data suggest that
the carboxy-terminus of Trs23p does not provide an essential
function to the protein and that the SMS domain is required
for some aspect of Trs23p function that can be compensated by
the carboxy-terminus of the protein.
An earlier report suggested that Trs23 containing the triple
point mutation M200A/P201W/R203S (herein referred to as
trs23
MPR/AWS) was lethal.
14 Since we have just demonstrated that
the carboxy-terminus of Trs23p, which contains the aforemen-
tioned residues, is not essential for growth, we re-examined the
growth characteristics of this triple point mutant. Consistent
with our trs23D99C mutant, we found that trs23
MPR/AWS was not
lethal but did in fact display a severe cs phenotype (Fig.1B
and C). We further found that trs23
MPR/AWS is not dominant
since neither a heterozygous diploid strain nor a haploid strain
containing trs23
MPR/AWS and wild-type TRS23 displayed any
growth defects. Although the reason for the discrepancy in the
lethality of trs23
MPR/AWS is not clear, the phenotype we now
show is consistent with the non-essential nature of the carboxy-
terminus of TRS23.
The SMS domain is required for efficient assembly of recom-
binant TRAPP I. To begin to address the consequences of the
removal of either the carboxy-terminus or the SMS domain of
Trs23p, we expressed these proteins in our recombinant bacterial
system that generates a functional TRAPP I complex (rTRAPP I)
that can be detected using size exclusion chromatography.
15 As
shown in Figure2A, although the truncated trs23D99C protein
was produced and could be detected by anti-Trs23p antibody in
the cell lysate, it was largely insoluble and did not co-purify with
His-tagged Bet3p. In contrast to the cells expressing wild-type
Trs23p where rTRAPP I is found in a high molecular size
fraction, rTRAPP I was absent in lysates expressing either the
trs23D99C or the trs23DSMS proteins (Fig.2B). Instead, cells
expressing trs23D99C contained a Bet3p-Trs33p-Bet5p sub-
complex while those expressing trs23DSMS contained a Bet3p-
Trs33p-Bet5p-trs23DSMS subcomplex.
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Since small amounts of rTRAPP I may be present in the
lysates generated from the two mutants, we assayed the lysate
for guanine nucleotide exchange factor (GEF) activity for the
GTPase Ypt1p since this activity is robust with rTRAPP I.
14,15
Compared to lysate containing wild-type Trs23p and consistent
with no detectable rTRAPP I, lysate with trs23D99C displayed
near background levels of GEF activity (Fig.2C). In contrast,
lysate prepared from cells expressing the trs23DSMS protein
displayed GEF activity intermediate to that of wild-type and
Ypt1p alone (Fig.2C) suggesting that small, but undetectable,
amounts of rTRAPP I do indeed form in these cells. Our results
suggest that, in vitro, rTRAPP I cannot assemble with the
trs23D99C protein. They further suggest that the SMS domain
of Trs23p is not essential for GEF activity of rTRAPP I but is
required for its efficient assembly.
The SMS domain contributes to Trs23p interactions. The
lack of efficient assembly of rTRAPP I in the presence of either
the trs23DSMS or trs23D99C proteins suggests that interactions
with other TRAPP subunits are abrogated. To test this notion,
wild-type Trs23p, trs23DSMS and trs23D99C were expressed
as fusion proteins with the Gal4p DNA binding domain. The
plasmid expressing these proteins was introduced into yeast
containing open reading frames encoding individual TRAPP
proteins fused to the Gal4 transcriptional activation domain.
Reconstitution of Gal4p-dependent transcription, and hence a
protein-protein interaction, was assessed by three criteria: growth
of the cells on medium (1) lacking histidine, (2) lacking both
histidine and adenine and (3) lacking histidine but containing
3-aminotriazole (3AT), a competitive inhibitor of His3p. Wild-
type Trs23p displayed interactions with Trs31p, Bet5p and
Trs20p (Fig.3A). Interactions with Trs31p and Bet5p were also
seen in the crystal structure of both the yeast and mammalian
proteins.
14,15 While an interaction with Trs20p was not detected
in the crystal structure, a similar interaction between the
mammalian homologs TRAPPC4 and TRAPPC2 was recently
reported
21 and may reflect interactions in higher ordered
Figure1. Growth properties of trs23 mutations. (A) MSY62 was transformed with a plasmid (pRS315) containing TRS23 that was subjected to either
random mutagenesis yielding nonsense mutations after the 17th, 52nd and 120th amino acids (trs23D202C, trs23D167C and trs23D99C, respectively); or
site-directed mutagenesis to generate a nonsense mutation after amino acid 110 (trs23D109C) or deletion of either the first 15 amino acids (trs23D15N)
or the SMS domain (trs23DSMS). Cells were plated on either SD-leucine or on 5-FOA to counterselect against wild-type TRS23 in the URA3-containing
plasmid pRS316 and incubated at 30°C. (B) Serial 10-fold dilutions of wild-type or yeast strains with the mutations indicated were plated on YPD and
incubated at either permissive temperature (30°C) or the restrictive temperatures of 16°C or 38°C. (C) A schematic showing all of the TRS23 mutations
used in this study with their viability and growth phenotypes indicated (cs, cold sensitive; ts, heat sensitive). (D) Human TRAPPC4 (accession number
NP_057230.1) and S. cerevisiae Trs23p (accession number NP_101532.1) were aligned using Clustal W and the gaps were inserted manually in accordance
with Kim et al., 2006. Identities are shaded in black, the PDZ-like domain of human TRAPPC4 is underlined and the SMS domain of Trs23p is shaded in
gray.
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structures.
25 The trs23D99C protein lost all of the interactions
seen with the wild-type protein, consistent with its inability to
support assembly of rTRAPP I. The trs23DSMS protein lost its
ability to interact with Bet5p and showed a weakened ability
to interact with both Trs31p and Trs20p (Fig.3A), suggesting
that the SMS domain contributes to these interactions. These
differences were not due to reduced expression levels or instability
of the mutant proteins (Fig.3B). Weakened interactions between
trs23DSMS and other TRAPP proteins helps to explain the
intermediate GEF activity seen in bacterial lysates containing
trs23DSMS (Fig.2C) in the absence of detectable amounts of
rTRAPP I (Fig.2B).
trs23DSMS retains Ypt1p GEF activity in yeast lysates.
We next explored the level of Ypt1p GEF activity in the yeast
mutants trs23DSMS and trs23D99C. In lysates prepared from
trs23DSMS, GEF activity was comparable to that of wild-type
(Fig.4A) confirming that this domain is not essential for GEF
activity. In contrast, lysates from trs23D99C were reduced to
near background levels and was similar to that of trs23
MPR/AWS
(Fig.4A) that was previously shown to be defective in vitro (see
ref. 14). These results are similar to those seen in vitro (Fig.2C)
and suggest that the assembly of TRAPP in trs23DSMS is more
efficient in vivo compared with in vitro. Furthermore, the stability
of TRAPP appears to be largely unaffected in trs23DSMS, in
contrast to trs23D99C where several subunits are less stable
(Fig.5). Reduced levels of TRAPP could account for the growth
phenotype seen for trs23D99C. For these reasons, we focused
our attention on the trs23DSMS mutant which, although has
weakened interactions, displays no defects in growth, TRAPP
subunit levels or GEF activity in yeast.
trs23DSMS contain only a single TRAPP peak at physio-
logical salt. Our results thus far suggest that the trs23DSMS
protein has reduced interactions with TRAPP proteins and only
weakly supports the formation of the TRAPP core in vitro yet
yeast bearing this mutation are not defective in GEF activity.
We therefore explored the effects of this mutation on the
formation of the three reported yeast TRAPP complexes TRAPP
I, II and III. Lysates from wild-type and trs23DSMS were
fractionated in physiological salt (150 mM) by size exclusion
chromatography on a Superose 6 column. This column was
chosen since, unlike Superdex 200 that has been used for most
previously-reported TRAPP studies, it readily separates TRAPP II
and III.
20 Consistent with previous studies,
7,11,18,20,26,27 Bet3p,
Trs23p and Trs33p in wild-type lysates are found in two high
molecular weight fractions (Fig.6A). While these have previously
been reported to correspond to TRAPP II and I on a Superdex
200 column, we now show the remarkable result that the highest
molecular weight peak (fractions 16–17) contains both the
TRAPP III- and II-specific subunits Trs85p and Trs130p,
respectively (Fig.6A). Only at higher salt concentrations
(300 mM) do we see these proteins separate into two peaks
largely distinct from each other which are indicated as TRAPP III
(fractions 16–17) and II (fractions 21–22) (Fig.6A). The third
TRAPP complex, TRAPP I, peaks at fractions 30–31 (Fig.6A).
In lysates from trs23DSMS, similar results were seen with respect
to the peak seen in fractions 16–17, and the salt-induced
Figure2. Assembly and function of recombinant TRAPP containing the
trs23D99C and trs23DSMS proteins. (A) Bacterial cells expressing
wild-type TRAPP I proteins (with His-tagged Bet3p and Trs33p) and
Trs23p (lanes 1–3) or trs23D99C (lanes 4–6) were probed for Trs23 using
anti-Trs23p antiserum either in the total cell lysate (TCL; lanes 1 and 4),
the soluble fraction (lanes 2 and 5) or in the eluate following a Ni
2+-NTA
agarose purification (lanes 3 and 6). (B) Bacterial cells expressing
wild-type TRAPP I proteins (where Bet3p is His-tagged) and Trs23p,
trs23D99C or trs23DSMS as indicated, were first purified with Ni
2+-NTA
agarose and then the eluates were fractionated by size exclusion
chromatography on a Superdex 200 column. Fractions from the column
were then analyzed by SDS-PAGE and the gel was silver stained. The
positions of the TRAPP proteins are indicated to the side of each panel
and the position on the column of fully-assembled recombinant TRAPP I
is indicated by an asterisk (*). (C) Lysates from the bacterial cells in (B)
were assayed for Ypt1p GEF activity as described in Experimental
Procedures (wild-type (&); trs23D99C (q); trs23DSMS (#). The intrinsic
ability of Ypt1p to release nucleotide is also shown (D). Assays represent
three replicates and error bars represent ± SEM.
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separation into distinct TRAPP III and II peaks was also noted
(Fig.6A). However, in trs23DSMS we no longer detected the
TRAPP I peak that appears in fractions 30–31 in wild-type cells.
Rather, the TRAPP subunits Bet3p, Trs23p and Trs33p are
found in a peak in fractions 33/34 (Fig.6A and B). This latter
peak has a molecular size of ~67 kD which likely corresponds
to monomers or very small subcomplexes of these subunits. In
addition, we noted the appearance of a sizeable pool of Trs85p
in trs23DSMS that increases under high salt conditions. The
complexes seen on this column are likely representative of the
cellular pool of TRAPP since the majority of TRAPP was loaded
onto the columns at both 150 mM and 300 mM salt (Fig.6C).
Collectively, our results demonstrate that, at physiological salt,
trs23DSMS contain just a single TRAPP peak corresponding to
the region where TRAPP III fractionates and that under these
conditions the TRAPP II peak is not present even in wild-type.
The fact that Trs85p and Trs130p co-fractionated in a single
peak at physiological salt in both wild-type and trs23DSMS led
us to consider the possibility that there is a single TRAPP com-
plex that is unstable and easily fragments with increasing salt.
Alternatively, these two TRAPP complexes could be either
oligomerized or bound to other cellular components causing
them to co-fractionate. To distinguish between these possibilities
we constructed a strain that contains TAP-tagged Trs85p and
Trs130p-myc. The strain was fractionated under conditions where
only the TRAPP III peak, but not the TRAPP II peak, was
detected (50 mM NaCl; see Fig.8A). The TRAPP III-containing
fraction was then treated with the crosslinking reagent DSP or left
untreated before processing for immunoprecipitation. Although
crosslinking was efficient (see Fig.8B), when Trs85p was
immunoprecipitated with anti-TAP IgG we failed to detect
co-precipitation of Trs130p-myc even though . 50% of the
cellular Trs85p was immunoprecipitated (Fig.6D). Since mul-
tiple copies of Trs85p were not previously detected in TRAPP
III
20 and since at least two copies of Trs130p are present in
TRAPP II,
25 we should have easily been able to detect co-
precipitation of Trs130p-myc if there was just a single complex
in fractions 16–17. Therefore, we conclude that at physiological
salt, TRAPP II and III represent distinct complexes that co-
fractionate on a Superose 6 column.
TRAPP II/III provides Ypt1p GEF activity in trs23DSMS.
The ability of TRAPP I to act as a GEF for Ypt1p is firmly
established.
7,14,15,18,28 The absence of TRAPP I in trs23DSMS
along with near wild-type levels of GEF activity in vivo, suggested
that an alternate Ypt1p GEF was functioning to support ER-to-
Golgi transport. One possibility is that Dss4p, a protein that
facilitates nucleotide release from several GTPases including
Ypt1p
29 and genetically interacts with TRAPP,
30 can facilitate
nucleotide exchange on Ypt1p in the absence of TRAPP I. If this
were the case, we would expect to see a genetic interaction
between DSS4 and TRS23. Since trs23D99C has an obvious
growth phenotype, we used this mutant to explore genetic
Figure3. The SMS domain of Trs23p contributes to the strength of Trs23p-TRAPP subunit interactions. (A) Wild-type Trs23p or the mutants trs23D99C
and trs23DSMS were expressed in yeast as fusion proteins with the DNA binding domain of Gal4p and mated to yeast strains expressing other TRAPP
subunits fused to the transcriptional activation domain of Gal4p. Serial 10-fold dilutions of diploids were plated on SD-leucine/tryptophan, SD-leucine/
tryptophan/histidine, SD-leucine/tryptophan/adenine and SD-leucine/tryptophan/histidine containing 5mM 3AT and all plates were incubated at 30°C. A
two-dimensional schematic of the TRAPP II complex is shown to the right of the panel. Shaded in gray is the TRAPP I core of the complex whose crystal
structures and organization are known. The position and interactions of the remaining subunits (stippled) are not known but are based on previously
published studies on the organization of yeast and mammalian TRAPP complexes.
25,27,36 (B) Lysates were produced from yeast cells expressing Trs23p, or
the mutant proteins trs23DSMS or trs23D99C from the plasmid pGBKT7. Equal amounts of protein were loaded in each lane and probed with anti-myc
IgG since the fusion proteins contain a myc epitope tag. Identical results were obtained when the blot was probed with anti-Trs23p IgG (not shown).
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interactions with DSS4. Overexpression of DSS4 did not alleviate
either the ts or cs phenotype of trs23D99C (not shown). In
addition, tetrad analysis following a cross between the two haploid
mutant yeast strains dss4D and trs23D99C did not reveal any
growth defect or exacerbation of the growth phenotype seen for
trs23D99C (22 tetrads dissected, co-segregation in 19 colonies).
These results argue against Dss4p compensating for the lack of
TRAPP I.
Alternatively, TRAPP II or III, the only TRAPP complexes
detected in trs23DSMS at physiological salt, may act as a Ypt1p
GEF since previous literature in this area in which lysates were
assayed for GEF activity has been controversial.
7,14,18,28 Yeast
lysates from wild-type and trs23DSMS were fractionated by size
exclusion chromatography on a Superose 6 column and fractions
16–17 (TRAPP II/III) and 29–31 (where TRAPP I fractionates)
were assayed for Ypt1p GEF activity. Indeed, both the TRAPP
II/III- and TRAPP I-containing fractions displayed Ypt1p GEF
activity in wild-type. In contrast, and consistent with the absence
of TRAPP I in trs23DSMS, this mutant only displayed Ypt1p
GEF activity in the TRAPP II/III fractions (Fig.4B). It is
noteworthy that although TRAPP III has been reported to display
Ypt1p GEF activity,
10 the Trs85p peak near TRAPP I is not active
in our assay, suggesting that only the high molecular weight
peak of Trs85p possesses this activity. Our results suggest that in
the absence of TRAPP I, either TRAPP II or III can provide
sufficient Ypt1p GEF activity to maintain cell growth.
trs23DSMS does not display defects in membrane traffic.
The only notable defect seen in trs23DSMS has been the
disappearance of its TRAPP I peak. Since TRAPP I is reported to
function in ER-to-Golgi transport, we expected that a defect
in this stage of membrane traffic would manifest in a growth
Figure4. GEF activity is unaffected in S. cerevisiae containing trs23DSMS.
(A) Lysates from yeast cells expressing wild-type Trs23p (&) or the
mutant proteins trs23D99C (q), trs23DSMS (#) or trs23
MPR/AWS (X) were
prepared and assayed for Ypt1p-directed GEF activity as described in
Experimental Procedures. The intrinsic ability of Ypt1p to release
nucleotide is also shown (m). (B) Lysate from wild-type (&)o rtrs23DSMS
(#) was fractionated by size exclusion chromatography on a Superose 6
column in 150mM salt. The fractions enriched in TRAPP II/III (fractions
16–17) and TRAPP I (fractions 29–31) were pooled, concentrated and
assayed for Ypt1p GEF activity compared with the intrinsic ability of
Ypt1p to release nucleotide. The intrinsic ability of Ypt1p to release
nucleotide is also shown (m). Assays in (A) and (B) represent three
replicates and error bars represent ± SEM.
Figure5. The levels of TRAPP subunits are largely unaffected in
trs23DSMS. Lysates from wild-type (lane 1), trs23
MPR/AWS (lane 2),
trs23DSMS (lane 3) and trs23D99C (lane 4) were probed with antibodies
recognizing the TRAPP subunits indicated or anti-HA to detect
endogenously-tagged Trs130p. Tubulin served as a loading control.
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phenotype. However, this was not seen (see Fig.1). In order to
more closely assess this mutant for possible defects in membrane
traffic we first examined the processing of the vacuolar protease
carboxypeptidase Y (CPY) by pulse-chase analysis. This protein
has ER (p1), Golgi (p2) and vacuolar (m) forms that are easily
distinguished by SDS-PAGE. As shown in Figure7A, trs23DSMS
did not show a noticeable defect in CPY processing. The pattern
was similar to wild-type and stood in stark contrast to that of
sec18, which displayed the expected block in ER-to-Golgi traffic
as evidenced by the failure of the cells to process p1CPY.
Since Trs23p is a component of TRAPP II that reportedly
functions at the late Golgi, we also examined the cells for defects
in later stages of the secretory pathway. Snc1p, a protein that
cycles between the late Golgi and the plasma membrane, is
normally found at steady-state on the plasma membrane of
unbudded yeast cells or on the emerging bud in a polarized
manner when fused to GFP (GFP-Snc1p).
31 Defects in recycling
lead to the accumulation of Snc1p inside of the cells or a loss of
its polarized distribution. Wild-type cells displayed the expected
distribution of GFP-Snc1p (Fig.7B). As was the case with CPY
processing, GFP-Snc1p localization was unaffected in trs23DSMS.
This result contrasts with that of trs85D which showed a strong
GFP-Snc1p recycling defect (Fig.7B) as previously reported.
27
To further explore trs23DSMS for a late secretory pathway
defect we examined the localization of the fluorescently-tagged
GTPase GFP-Ypt31p. This GTPase normally concentrates in
small buds and at the mother/bud neck,
32 which we saw in wild-
type cells (Fig.7C). This pattern was unaffected in trs23DSMS,
in contrast to trs23D99C where it was clearly altered (Fig.7C).
TRAPP III has recently been reported to function in auto-
phagy.
10 We therefore examined the cytosol-to-vacuole targeting
(cvt) pathway in trs23DSMS using the marker Ape1p-GFP. This
protein is processed by the cvt pathway and is ultimately
cleaved releasing GFP which is detected by western analysis.
33
As shown in Figure7D, both wild-type and trs23DSMS were
capable of processing Ape1p-GFP. In contrast, and as previously
reported,
12,13 trs85D cells were defective in this pathway
(Fig.7D).
We also examined trs23DSMS for defects in an in vitro assay
that reconstitutes ER-to-Golgi transport.
34 This assay measures
the acquisition of Golgi-specific modifications of a marker protein
called pro-a-factor. Compared with wild-type, trs23DSMS did
not show a defect in transport in vitro (Fig.7E). As was shown
earlier using physiological salt (see Fig.6A), lysates from
trs23DSMS prepared in the buffer used for the in vitro assay
(buffer B88) also showed a single TRAPP peak corresponding
to TRAPP II/III (Fig.7F). Interestingly, lysates from wild-type
used for this assay showed a broadening of the TRAPP I peak
suggesting this complex is not stable in this buffer. Collectively,
our results suggest that trs23DSMS does not adversely affect
membrane traffic in vitro nor in vivo.
TRAPP I can form from TRAPP II/III in vitro. Our results
thus far suggest that in the absence of TRAPP I, cells survive
with no adverse effects in ER-to-Golgi traffic. This was surpris-
ing given that TRAPP I is implicated in this pathway. One
explanation is that TRAPP I represents either an intermediate in
the assembly of TRAPP II and/or III or is a fragment of either
complex since we found that its appearance is salt-dependent
(Fig.8A). To address this we first fractionated a lysate from wild-
type cells in low (50 mM) salt where only the TRAPP II/III peak
is detected (Fig.8A). We then incubated this fraction either with
or without the crosslinking reagent DSP and fractionated the
sample in 300 mM salt, conditions where all three TRAPP
complexes are detected (see Fig.6A). As shown in Figure8B,
while the untreated sample did indeed show a TRAPP I peak,
the crosslinked sample did not. Importantly, no intermediate
peak between TRAPP II/III and TRAPP I was detected in the
untreated sample. These results suggest that TRAPP I is a sub-
complex of one or both of the larger (TRAPP II and III)
complexes that forms in the presence of increasing salt in vitro.
TRAPP I appearance is SMS domain-dependent. TRAPP I, as
defined by the co-fractionation of the TRAPP core subunits on
a gel filtration column, is readily seen in S. cerevisiae but not in
human cells.
21,22,35,36 We speculated that this may be due to added
stability afforded to this complex by the SMS domain of Trs23p.
Like the human protein, Trs23p in other yeast such as P. pastoris
do not have the SMS domain. Thus, if our hypothesis is correct,
we would expect that P. pastoris would not display a TRAPP I
peak. We found that our antibody raised against the human
TRAPPC3 protein, the most conserved subunit in TRAPP, was
cross-reactive with P. pastoris Bet3p providing us with a means
to address whether this yeast has a TRAPP I peak. Lysate from
P. pastoris and S. cerevisiae was fractionated by size exclusion
chromatography on a Superdex 200 column to better resolve the
smaller molecular size region where TRAPP I fractionates. In
S. cerevisiae, TRAPP I is detected in fraction 13 while TRAPP
II/III is detected in fractions 8–9( Fig.9). In the P. pastoris lysate,
a high molecular weight pool of Bet3p was detected that most
likely corresponds to TRAPP II/III (Fig.9). Based on the size of
the P. pastoris TRAPP subunits, a TRAPP I complex would be
expected to be only 30 kD smaller than the S. cerevisiae complex.
While a second peak of Bet3p was detected, it eluted in a fraction
(fraction 17) with a molecular size much smaller than that
expected for TRAPP I and no other peak of P. pastoris Bet3p was
seen. The absence of a TRAPP I-equivalent was also noted for
human cells, whose Trs23p homolog does not contain an SMS
domain.
21,22,36,37 This result is consistent with the notion that the
SMS domain of Trs23p stabilizes S. cerevisiae TRAPP I.
Discussion
Here we demonstrate that the Saccharomycotina-specific (SMS)
domain of S. cerevisiae Trs23p is not required for Ypt1p-directed
GEF activity but is important for the stable interaction between
Trs23p and other TRAPP subunits. Our data suggest that cells
devoid of this domain of Trs23p contain two large TRAPP
complexes called TRAPP II and III and do not contain the smaller
TRAPP I complex. These cells resemble wild-type with respect to
four different membrane trafficking assays both in vivo and in
vitro and in terms of their growth characteristics. Based on our
study, we suggest that the SMS domain of Trs23p stabilizes
fragments (TRAPP I) of TRAPP II and/or III.
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Collectively, our data may suggest that S. cerevisiae contain a
single Golgi-localized TRAPP complex (TRAPP II) that is capable
of supporting ER-to-Golgi traffic. This is based on a number of
observations including: (1) removal of the SMS domain of Trs23p
in S. cerevisiae results in a loss of the TRAPP I peak with no
corresponding reduction in Ypt1p GEF activity or noticeable
growth phenotype; (2) ER-to-Golgi traffic is normal both in vivo
and in vitro; (3) a TRAPP I peak can be formed by incubating the
TRAPP II/III peak with high salt in vitro. Since TRAPP II, but
not TRAPP III, localizes to the Golgi we propose that TRAPP II
can function in ER-to-Golgi transport. Since we cannot separate
TRAPP II from III, we cannot rule out the possibility that
TRAPP III is the complex that functions in ER-to-Golgi traffic.
In this respect it is noteworthy that depletion of Trs85p, the
TRAPP III-specific subunit, was reported to be defective in ER-
to-Golgi traffic
7 and autophagy may use membranes derived from
the ER
38 suggesting the possibility that the role of TRAPP III in
autophagy may be an indirect result of its role in ER-to-Golgi
traffic.
An important next step will be to characterize the TRAPP II
and III superstructures that we report. We have shown an
identical fractionation pattern to that seen in Figure6A in the
presence of Triton X-100 for the TRAPP II subunit Trs130p
(S.B. and M.S., unpublished observation), suggesting that these
structures are either bound to detergent-insoluble membranes,
they oligomerize to greater than a dimer or are bound to a large
protein structure as previously suggested.
16 In addition, unchar-
acterized subunits may be present in the complex. An alternative
explanation for our data are that in the trs23DSMS cells, TRAPP I
is more tightly associated with the TRAPP superstructures and
would require higher salt to be liberated. We do not favor this
possibility since increasing the salt concentration in trs23DSMS
redistributes TRAPP core proteins from the higher molecular size
fractions to a smaller fraction. The resulting peak is significantly
smaller than TRAPP I and, at physiological salt, is devoid of
Trs23p. It is evident that data addressing the existence and
function of TRAPP I (which has only been demonstrated in vitro)
as an independent TRAPP complex must be cautiously inter-
preted in light of our in vitro data.
Our results implicate the SMS domain of Trs23p in the
stability of TRAPP I. The added stability afforded to TRAPP I by
the SMS domain may explain why a recombinant form of human
TRAPP I could not be assembled like that seen for the S. cerevisiae
subunits.
15 Although it remains a formal possibility that small
amounts of TRAPP I can support growth with no observable
phenotype, given the very low levels of TRAPP in cells to begin
with
16 and the amounts of TRAPP I needed to support ER-to-
Golgi transport in vitro,
7 as well as the lack of GEF activity in the
TRAPP I fraction of trs23DSMS (Fig.4B) we do not favor this
possibility.
Consistent with the notion that TRAPP I may be a fragment of
TRAPP II or III is the fact that TRAPP I is not detected in live
yeast cells.
27 In addition, it has previously been shown that the
relative distribution of core subunits between the two TRAPP
peaks on a Superdex 200 size exclusion column (which does not
resolve TRAPP II and III) is highly variable but TRAPP II/III
levels of these subunits are generally higher than those in TRAPP
I.
7,20,26,27 The only exceptions to this are when high salt (500 mM)
is used in the preparation of the lysate
27 or when certain trs120 or
trs130 (TRAPP II) mutants are used.
26 The former is consistent
with the notion that TRAPP I is an in vitro, salt-dependent
fragment of TRAPP II and/or III, and the latter is consistent with
the role of Trs120p and Trs130p in the overall architecture of
TRAPP II.
25 The notion that TRAPP I results from TRAPP II/III
is analogous to a recent study that suggested that there were two
Trs85p peaks on a size exclusion column (confirmed in the
present study), where the low molecular weight peak may
represent a breakdown product or an assembly intermediate of the
higher molecular weight TRAPP III peak.
20
If our suggestion of TRAPP I being an in vitro, salt-dependent
fragment of TRAPP II/III is correct, this has strong implications
for the role of tethering factors as determinants of specificity and
for the mechanism of action of TRAPP in ER-to-Golgi traffic in
particular. The Golgi would in fact have a single TRAPP complex
(TRAPP II) that could function in traffic at both ends of the
organelle. In mammalian cells the early secretory pathway is more
complex with a pre-Golgi ERGIC compartment
39 and the need to
transport diverse-sized cargo.
40 Whether the mammalian TRAPP
complex functions at both ends of the Golgi is still unknown.
However, it has been shown to function in the early secretory
pathway
21,22,36,37,41 and only a single complex containing all S.
cerevisiae TRAPP subunit homologs has been reported, suggesting
Figure6 (See opposite page). A single TRAPP peak is detected in trs23DSMS at physiological salt concentrations. (A) Lysates from wild-type and
trs23DSMS were fractionated on a Superose 6 size exclusion column in buffer containing either 150mM NaCl or 300mM NaCl as indicated. Fractions of
0.5 ml were collected and probed with antibodies that recognize Bet3p, Trs33p, Trs23p or HA (to detect endogenously-tagged Trs130p or Trs85p). I, II
and III above the wild-type and trs23DSMS blots indicate the location of TRAPP I, II and III, respectively, under conditions where they separate from each
other. Molecular size standards are also indicated above the blots. Note that a cross-reactive band appears just above the Trs33p band in fractions 32–34
with the anti-Trs33p antibody and the dash to the right of the Trs33 panels indicates the position of Trs33p. For each subunit shown, samples ranging
from fractions 14–38 were fractionated on two separate polyacrylamide gels and processed for western analysis simultaneously. Exposures for each half
of the two gels were identical. (B) The signals for Trs33p (top panel) and Trs23p (bottom panel) from wild-type (green) and trs23DSMS (blue) at 150mM
NaCl shown in (A) were quantitated using Image J and plotted as a percentage of the total signal. Note the absence of the TRAPP I peak in trs23DSMS. (C)
Lysates were prepared for fractionation as in (A) at either 150mM or 300mM NaCl. Samples before the centrifugation (T), the pellet fraction following
centrifugation (P) and the supernatant (S) that was loaded onto the Superose 6 column were probed for Trs23p in both wild-type and trs23DSMS. (D)
Lysate from wild-type cells containing Trs85p-TAP and Trs130p-myc were fractionated on a Superose 6 column and fractions 16–17 were collected and
split in two. One sample was treated with DMSO while the other sample was treated with the crosslinking reagent DSP for 3 h on ice. Each sample was
then split in two and either treated with (+) or without (-) anti-TAP IgG. The immune complexes were collected on protein A-sepharose beads,
fractionated by SDS-PAGE and probed with anti-myc IgG. Samples representing 10% of the input are shown.
www.landesbioscience.com Cellular Logistics 9© 2012 Landes Bioscience.
Do not distribute.
that if mammalian TRAPP does indeed function at the late
Golgi then a single complex would be expected to perform both
of these functions. Indeed, parallels between S. cerevisiae and
human TRAPP proteins with respect to their interactions with
vesicle coat proteins have already been made.
9,17,22 We suggest
that factors on the vesicles (e.g., GTPases and SNAREs) in
combination with coat proteins and tethers contribute to the
overall specificity of vesicle transport. This notion helps to explain
why some GTPases such as Ypt1p can function at multiple steps
in membrane traffic
10,42-44 and why some yeast SNAREs such
as Sed5p, Ykt6p and Vti1p can also function in multiple
membrane trafficking processes.
45-48 In this respect, S. cerevisiae
TRAPP II and mammalian TRAPP would be no different, with
the particular combinations of factors and the combined effect
of multiple layers of partial specificity dictating the overall
specificity of the process.
Figure7. For figure legend, see page 11.
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Whether S. cerevisiae TRAPP functions on the Golgi where it
interacts with incoming vesicles or binds to vesicles and interacts
with a Golgi-localized protein is not clear and needs to be
resolved. However, recent studies suggest the latter may be
possible
9,17,22 and the mammalian Bet3p homolog, TRAPPC3,
has been shown to be required for homotypic vesicle fusion
suggesting that at least this subunit can bind to vesicles
independent of the Golgi.
41 In addition, other MTCs or parts
of these complexes such as the exocyst and the COG complex
have been reported to localize to vesicles
49-51 leaving open the
question of whether MTCs bind first to vesicles or target
organelles. If TRAPP were to function analogously, it would have
the ability to bind to both COP I and II vesicles.
Given the large size of TRAPP II and III, and the fact that the
core subunit Bet3p binds to the inner Sec23/24p layer of the
COP II coat, how can we envision TRAPP II or III functioning in
ER-to-Golgi transport? The dimensions of a TRAPP II dimer
(225 Å  250 Å)
52 may in theory have access to the Sec23/24p
layer since the outer layer, composed of Sec13/31p, has openings
Figure7 (See opposite page). Membrane trafficking is unaffected in the trs23DSMS mutant. (A) Wild-type, trs23DSMS and sec18 yeast were pulse-
labeled with
35S-methionine/cysteine and chased for the times indicated below the panels. Carboxypeptidase Y (CPY) was immunoprecipitated from
lysates at each time point, fractionated by SDS-PAGE and visualized by autoradiography. The position of the ER (p1) and vacuolar (m) forms of CPY are
indicated. (B) Wild-type, trs23DSMS and trs85D were transformed with a plasmid expressing GFP-Snc1p. The cells were fixed and viewed using an
epifluorescence microscope. (C) Wild-type, trs23DSMS and trs23D99C were transformed with a plasmid expressing Ypt31p-GFP. The cells were fixed and
viewed using an epifluorescence microscope. For quantitation in (B) and (C), a minimum of 100 cells from three replicates were counted. The error bars
represent ± SEM and representative cells used for quantitation are shown as insets. (D) Wild-type, trs23DSMS and trs85D were transformed with a
plasmid expressing Ape1p-GFP, grown in minimal medium without uracil, converted to spheroplasts and lysed. Samples were fractionated by SDS-PAGE
and probed with anti-GFP. The percentage of Ape1p-GFP processing, calculated using Image J, is indicated below each lane. (E) Reconstitution of ER-to-
Golgi traffic was performed as described in Experimental Procedures. Reactions were performed with no additions either on ice (ice) or at 29°C (NA), or
fully reconstituted at 29°C (Recon). The results are expressed as percentage of concanavalin A-precipitable pro-a-factor that has received a-1,6-mannose
Golgi modifications. The results are the average of duplicates and the range of transport over three independent experiments was 13.6–15.4% (wild-type)
and 12.6–14% (trs23DSMS). (F) Lysates were prepared from wild-type and trs23DSMS in buffer B88 that was used for the in vitro transport assay in (E) and
fractioned on a Superose 6 column in B88. Fractions were probed with anti-Trs33p. I, II and III above the blots indicate the location of TRAPP I, II and III,
respectively, under conditions where they separate from each other.
Figure8. TRAPP I can form from TRAPP II/III. (A) Lysates of wild-type yeast were prepared in buffer containing 50mM, 150mM or 300mM NaCl and
fractionated by size exclusion chromatography on a Superose 6 column in buffer containing identical salt. The fractions were analyzed by western
blotting for the presence of Trs23p. (B) The TRAPP II/III-containing fraction from wild-type lysate that was fractionated in the presence of 50 mM NaCl was
incubated with 2mM DSP or DMSO, quenched with Tris pH 7.5 and re-fractionated on a Superose 6 column in buffer containing 300mM NaCl. Fractions
were probed for the presence of Trs33p. Note that a cross-reactive band appears just above the Trs33p band in fractions 32–34 with the anti-Trs33p
antibody in the DMSO-treated sample and the dash to the right of the Trs33 panel indicates the position of Trs33p. I, II and III above the wild-type and
trs23DSMS blots indicate the location of TRAPP I, II and III, respectively, under conditions where they separate from each other.
Figure9. P. pastoris does not contain a TRAPP I peak. Lysates in 150mM
NaCl from P. pastoris and S. cerevisiae were fractionated by size exclusion
chromatography on a Superdex 200 column. The fractions were probed
for Trs33p (S. cerevisiae)o rP. pastoris Bet3p using anti-TRAPPC3 IgG. The
positions of TRAPP II/III and I are indicated above the top panel.
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of ~300 Å
52. However, TRAPP II superstructures, such as those
we presently demonstrate to occur at physiological salt, would
seem to be prohibitively large to have similar access. In addition,
it is unlikely that the openings presented by the COP II cage
are completely unobstructed given the density and numbers of
proteins that can be found on vesicles.
53 In the case of COP II
vesicles formed in vitro, the extent to which the outer layer of the
coat remains intact is unclear
54 and it has been suggested that
either a portion of each vesicle has lost its outer layer or a portion
of the vesicle population has lost its entire outer layer.
55 In this
case, the question of access of either TRAPP II or III to the Sec23/
24p layer would be mitigated. It is important to stress that the
extent to which the vesicle coat remains intact in vivo is not
known.
Materials and Methods
Strain construction. A list of all strains used in this study is
shown in Table 1. All trs23 mutations were constructed using the
same parental strain (MSY62). The trs23 mutations were
generated using the splicing by overlap extension PCR method
or random mutagenesis. Mutant strains were created by plasmid
shuffling using 5-fluoroorotic acid (5-FOA) counterselection.
Endogenous TRS130 and TRS85 were tagged at the carboxy-
terminus with a hemagglutinin (HA) epitope by genomic
insertion of a cassette amplified from pFA6a-3HA-HIS3MX6.
56
Insertion at the correct location was verified by PCR and western
blot analysis.
Spotting. Yeast strains were inoculated into 3 ml of minimal
media and grown in a shaker incubator overnight at 30°C.
The OD600 was normalized to the lowest value and 10-fold
serial dilutions were spotted onto minimal media with 5-FOA
or YPD (1% yeast extract, 2% peptone, 2% glucose). Yeast
were placed at the permissive temperature of 30°C to serve as
a growth control and at the restrictive temperatures of 16°C
and 38°C.
Preparation of yeast lysates. For fractionation of yeast cyto-
sols, cells were grown to mid log phase (OD600 of 1–1.5) over-
night at 25°C. Cells were converted to spheroplasts as previously
described.
57 Spheroplasts were lysed in lysis buffer [20 mM
HEPES pH 7.3, 2 mM EDTA, 50–300 mM NaCl, 1 mM DTT,
and 1X protease inhibitor cocktail (PIC)], dounce homogenized
and centrifuged at 21,000 g (high speed spin) in an SW55Ti rotor
for 15 min at 4°C.
For GEF assays, membrane extraction and subcellular frac-
tionation and examining levels of TRAPP proteins, cells were
grown to early log phase (OD600 of 1–1.5) overnight at 25°C.
Cells were converted to spheroplasts as above, lysed in lysis buffer
(20 mM HEPES pH 7.3, 1 mM DTT, 1x PIC), dounce
homogenized and centrifuged at 500 g for 5 min to remove
unbroken cells and debris. The supernatant was centrifuged at
16,000 g (low speed spin) in a table-top microcentrifuge for
10 min at 4°C.
Sucrose gradient fractionation and membrane floatation. For
equilibrium fractionation, the 16,000g pellet from 400 OD600
units of starting material was resuspended in 500 ml of 5% sucrose,
dounce homogenized and layered on top of a discontinuous
sucrose gradient (1 ml each of 10%, 15%, 20%, 25%, 30%,
35%, 40%, 45%, 50%, 55% and 500 ml of 60% sucrose).
Gradients were centrifuged for 17 h at 178,000 g in an SW41Ti
rotor at 4°C. Fractions of 500 ml were collected from top to
bottom with a peristaltic pump.
For membrane floatation the 16,000 g pellet from 400 OD600
units of starting material was resuspended in 500 ml of 60%
sucrose and placed on the bottom of a centrifuge tube. A dis-
continuous step sucrose gradient was layered on top (1 ml each of
50%, 40%, 30%, 20% and 10% sucrose) and gradients were
centrifuged for 4 h at 178,000 g in an SW55Ti rotor. Fractions
of 500 ml were collected from top to bottom with a peristaltic
pump. Sucrose solutions (w/w) were dissolved in 20 mM HEPES
pH 7.3.
Size exclusion chromatography. For comparison between
wild-type and trs23DSMS, 5 mg of total protein from a
21,000 g supernatant was fractionated in the following gel
filtration buffer: 20 mM HEPES pH 7.3, 50–300 mM NaCl,
1 mM DTT (this component was excluded in crosslinking
experiments). In Figure7 buffer B88 was used.
34
Concentrated AKTA fractions for guanine nucleotide exchange
factor assays (see below) were prepared by fractionating 20 mg of
total protein from a 21,000 g supernatant (10 mg at a time) and
fractions were concentrated using a Millipore Amicon centrifugal
filter to a final volume of 200 ml. Gel filtration buffer contained
150 mM NaCl.
Samples were injected onto either a Superose 6 or a Superdex
200 column (GE Healthcare) connected to an AKTA liquid
chromatography system. Fractions of 0.5 ml were collected and
re-suspended in Laemmli sample buffer, fractionated by SDS-
PAGE and analyzed by western blotting. Endogenous Trs33p,
Bet3p and Trs23p were detected using polyclonal antibodies
raised in rabbits, the HA epitope was detected using a
commercially available monoclonal antibody (HA.7, Sigma), the
myc epitope was detected using the monoclonal antibody 9E10
and the TAP tag was detected with anti-TAP antibody
(OpenBiosystems).
Recombinant protein. Yeast TRAPP subunits were expressed
and purified from E. coli BL21(DE3) cells as previously
described.
15 Bet3p and Trs33p subunits were 6xHis-tagged and
complexes were purified using Ni
2+-NTA (Qiagen) followed by
size-exclusion chromatography on a Superdex 200 column.
Bacterial lysates. Yeast TRAPP subunits were expressed in
E. coli BL21 (DE3) cells as for recombinant protein (see above).
Cells were sonicated in lysis buffer (20 mM HEPES pH 7.3,
1 mM DTT) and the lysates were clarified by centrifugation at
30,000 g in a JA25.50 rotor (Beckman) prior to their use in
guanine nucleotide exchange factor assays.
Guanine nucleotide exchange factor (GEF) assays. GEF assays
were performed as previously described.
19 Each reaction was
started in a volume of 80 ml with yeast or bacterial lysates added
to a final concentration of 4 mg/ml. For Ypt1p alone, bovine
serum albumin (BSA) or E. coli BL21(DE3) lysate was added to a
final concentration of 4 mg/ml. The zero minute time point for
each sample was taken immediately after the pre-loaded Rab was
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added and 18 ml was removed for each subsequent time point.
Percent
3H-GDP remaining was based on the individual zero for
each sample.
In vivo and in vitro trafficking assays. The CPY pulse chase
experiment was performed as previously described with some
modifications.
58 Five OD600 units of cells in early log phase
(OD600 1–1.5) were temperature shifted in a shaking 38.5°C
water bath for 30 min. Cells were labeled with 250 mCi of
35S-
methionine/cysteine (Promix, Perkin-Elmer) (pulsed) for 4 min
followed by the addition of cold methionine/cysteine (chased) at a
final concentration of 10 mM. The zero time point was taken
immediately after the cold methionine/cysteine was added. Cells
Table1. Yeast strains used in this study
MSY20 MATa can100 leu2–3112 his3–11 trp1D ura3–1 ade2–1
MSY62 MATa his3D1 leu2D0 ura3D0 MET15trs23D::KanMX pRS316-TRS23
MSY107 MATa his3D1 leu2D0 ura3D0MET15 trs23D::KanMX pRS316-TRS23 pRS315-trs23D202C
MSY109 MATa his3D1 leu2D0 ura3D0 MET15trs23D::KanMX pRS316-TRS23 pRS315-trs23D167C
MSY118 MATa his3D1 leu2D0 ura3D0 MET15trs23D::KanMX pRS315-trs23D99C
MSY119 MATa his3D1 leu2D0 ura3D0 MET15 trs23D::KanMX pRS315-TRS23
MSY243a MATa his3D1leu2D0 ura3D0 MET15 trs23D::KanMX pRS316- trs23D99C
MSY245 MATa his3D1 leu2D0 ura3D0 MET15 trs23D::Neurseothricin pRS316-TRS23
MSY251 MATa his3D1 leu2D0 ura3D0 MET15 trs23D::KanMX pRS316-TRS23 pRS315-trs23
MPR/AWS
MSY297 MATa his3D1 leu2D0 ura3D0 MET15 trs23D::KanMX pRS316-TRS23 pRS315- trs23DSMS
MSY366 MATa trp1–901 leu2–3 112 ura3–52 his3–200 gal4D gal80D LYS2::GAL1UAS-GAL1TATA-HIS3 GAL2UAS-GAL2TATA-ADE2 URA3::MEL1UAS-
MEL1TATA-lacZ pGADT7-BET5
MSY367 MATa trp1–901 leu2–3 112 ura3–52 his3–200 gal4D gal80D LYS2::GAL1UAS-GAL1TATA-HIS3 GAL2UAS-GAL2TATA-ADE2 URA3::MEL1UAS-
MEL1TATA-lacZ pGADT7-TRS20
MSY370 MATa trp1–901 leu2–3 112 ura3–52 his3–200 gal4D gal80D LYS2::GAL1UAS-GAL1TATA-HIS3 GAL2UAS-GAL2TATA-ADE2 URA3::MEL1UAS-
MEL1TATA-lacZ pGADT7-TRS31
MSY449 MATa ura3–52 his3–200 ade2–101 trp1–901 leu2–3 112 met- gal4D gal80D URA3::GAL1UAS-GAL1TATA-lacZ pGBKT7GTWY-TRS23
MSY450 MATa ura3–52 his3–200 ade2–101 trp1–901 leu2–3 112 met- gal4D gal80D URA3::GAL1UAS-GAL1TATA-lacZ pGBKT7GTWY- trs23DSMS
MSY453 MATa trp1–901 leu2–3 112 ura3–52 his3–200 gal4D gal80D LYS2::GAL1UAS-GAL1TATA-HIS3 GAL2UAS-GAL2TATA-ADE2 URA3::MEL1UAS-
MEL1TATA-lacZ pGADT7
MSY458 MATa his3D1 leu2D0ura3D0MET15trs23D::KanMX pRS315-trs23D99C pRS416-GFP-SNC1
MSY459 MATa his3D1 leu2D0 ura3D0 MET15 trs23D::KanMX pRS315-TRS23 pRS416-GFP-SNC1
MSY460 MATa his3D1 leu2D0 ura3D0 MET15 trs23D::KanMX pRS315- trs23
MPR/AWS
MSY471 MATa his3D1 leu2D0 ura3D0 MET15 trs23D::KanMX pRS315- trs23DSMS
MSY474 MATa his3D1 leu2D0 ura3D0 MET15 trs23D::KanMX TRS130–3xHA::HIS3 pRS315- trs23D99C
MSY475 MATa his3D1 leu2D0 ura3D0 MET15 trs23D::KanMX TRS130–3xHA::HIS3 pRS315-TRS23
MSY478 MATa can100 leu2–3112 his3–11 trp1D ura3–1 ade2–1 trs85D::HIS3 pRS416-GFP-SNC1
MSY485 MATa his3D1 leu2D0 ura3D0 MET15 trs23D::KanMX pRS316- trs23D99C pRS315 GFP-YPT31
MSY486 MATa his3D1 leu2D0 ura3D0 MET15 trs23D::KanMX pRS316-TRS23 pRS315 -GFP-YPT31
MSY531 MATa his3D1 leu2D0 ura3D0 MET15 trs23D::KanMX TRS130–3xHA::HIS3 pRS315- trs23
MPR/AWS
MSY532 MATa his3D1 leu2D0 ura3D0 MET15 trs23D::KanMX TRS130–3xHA::HIS3 pRS315-trs23DSMS
MSY545 MATa his3D1 leu2D0 ura3D0 MET15 trs23D::KanMX pRS316-TRS23 pRS315-trs23D15N
MSY546 MATa his3D1 leu2D0 ura3D0 MET15 trs23D::KanMX pRS316-TRS23 pRS315- trs23D109C
MSY560 MATa his3D1 leu2D0 ura3D0MET15 trs23D::KanMX pRS315-trs23DSMS pRS416-GFP-SNC1
MSY561 MATa his3D1 leu2D0 ura3D0MET15 trs23D::KanMX pRS315-trs23DSMS TRS85–3xHA::HIS3
MSY563 MATa his3D1 leu2D0 ura3D0MET15 trs23D::KanMX pRS315-TRS23 TRS85–3xHA::HIS3
MSY570 MATa his3D1 leu2D0 ura3D0 MET15trs23D::KanMX pRS315-TRS23 pRS416-APE1-GFP
MSY572 MATa his3D1 leu2D0 ura3D0 MET15trs23D::KanMX pRS315-trs23DSMS pRS416- APE1-GFP
MSY573 MATa his3D1 leu2D0 lys2D0 ura3D0 YDR108w(trs85D)::KanMX pRS416- APE1-GFP
MSY580 MATahis3D1 leu2D0 ura3D0MET15 trs23D::KanMX pRS316-trs23DSMS pRS315-GFP-YPT31
MSY582 MATa/a his3D1/his3D200 leu2D0/leu2-3,112 ura3D0/ura3-52 LYS2/lys2-801 MET15/met15D0 SUC2/ suc2D9 CAN1/can1::hisG TRS130/
TRS130–13xmyc::HIS3 TRS85/TRS85-TAP::HIS3MX6
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were chased for a total of 30 min with an equal volume of cells
being removed every 10 min. Cells from each time point were
converted to spheroplasts, lysed and CPY was immunoprecipi-
tated overnight using a rabbit polyclonal anti-CPY antibody
(Abcam). Immunoprecipitated CPY was fractionated by SDS-
PAGE and the amounts loaded were normalized to the counts
per minute measured from whole cell lysates. The gel was
Coomassie-stained, dried and labeled CPY was detected by
autoradiography.
Microscopy-based assays (GFP-Snc1p, GFP-Ypt31p) were
performed by transforming yeast with the appropriate plasmid.
Cells were grown to early log phase overnight at 25°C and 5
OD600 units of cells were resuspended in 1 ml of 3.7% para-
formaldehyde (PFA), incubated at room temperature for 15 min,
pelleted and resuspended in ice cold methanol for 5 min. Cells
were then washed with wash buffer (1.4 M sorbitol, 50 mM KPi,
pH 7.5) and resuspended in 100 ml of the same buffer. Cells were
visualized using a Zeiss axioplan microscope fitted with an X-cite
series 120Q light source (EXFO Life Sciences) and a Lumenera
Infinity 3–1C 1.4 megapixel cooled CCD camera.
The in vitro reconstituted ER-to-Golgi assay using purified
proteins was performed as described.
34
Maturation of Ape1p-GFP was performed by first transform-
ing the plasmid into yeast. The cells were then grown overnight
to early log phase in minimal medium lacking uracil at which
point they were converted to spheroplasts and lysed in 20 mM
HEPES, pH 7.3, 100 mM NaCl, 0.1 mM DTT, 2 mM EDTA
with protease inhibitors. Equal amounts of protein were fraction-
ated by SDS-PAGE, transferred to PVDF membrane and probed
with mouse anti-GFP (Roche). Quantitation was performed using
Image J freeware.
Yeast two-hybrid assay. TRS23 and variants of this protein
were cloned into a Gateway
1-modified pGBKT7 vector
(pGBKT7GTWY).
21 All other TRAPP subunits were cloned into
the pGADT7 vector by restriction enzyme cloning. Mating and
analysis were as described by Scrivens et al.
21
Chemical crosslinking. Fractionated samples in gel filtration
buffer (50 mM NaCl) were treated with 2 mM dithiobis
[succinimidyl] propionate (DSP) for 3 h on ice. The reaction
was quenched by adding Tris pH 7.5 to a final concentration of
20 mM and incubating at room temperature for 15 min. For
immunoprecipitation, the sample was diluted with gel filtration
buffer (100 mM NaCl) containing 1% Triton X-100 and
incubated with 2 mg IgG overnight on ice. The next day, immune
complexes were collected on protein A beads, washed with lysis
buffer and processed for western analysis. In some experiments
the crosslinked samples were re-fractionated on a Superose 6
column as described above.
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